Medtronic Neuromodulation 2022-06-01 Health serious FDA
Health · FDA · Recall #FDA-Z-1123-2022
Vanta INS Implantable Neurostimulator. Medtronic Model 977006 Vanta with AdaptiveStim… Recall
Issued June 1, 2022 · Medtronic Neuromodulation
In June 2022, Medtronic Neuromodulation recalled the Vanta INS Implantable Neurostimulator. Medtronic Model 977006 Vanta with AdaptiveStim…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The Implantable Neurostimulator Model may be susceptible to not communicating with the clinical programmer and/or patient programmer system.
What you should do
- 1 Stop using Vanta INS Implantable Neurostimulator. Medtronic Model 977006 Vanta with AdaptiveStim… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Medtronic Neuromodulation to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Medtronic Neuromodulation
- Category
- Health
- Recall date
- June 1, 2022
- Units affected
- Not reported
- Sold at
- Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA,
- Recall number
- FDA-Z-1123-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Medtronic Neuromodulation has 5 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.